Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method. 1995

M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
Department of Clinical Virology, Göteborg, University, Sweden.

A new method for detecting the hepatitis B virus (HBV) precore 1896 G-->A mutation is described. This mutation prevents hepatitis B e antigen production by introducing a TAG stop codon and has been associated with severe chronic and fulminant hepatitis. The method is based on a polymerase chain reaction (PCR) that creates a restriction enzyme (Bsu36I) cleavage site if the mutation is present. After incubation of the PCR product with Bsu36I and a subsequent agarose gel electrophoresis, the presence of the TAG mutant is revealed by an altered position of the DNA band. The method was compared with direct sequencing on 36 serum samples and correctly identified all samples containing mutant HBV. The TAG mutant was present in 17 cases (as mixed wild type and mutant virus in 4). Twelve of 18 patients with advanced liver disease confirmed by biopsy carried mutant HBV. This method of detecting HBV precore 1896 G-->A should be useful for evaluation and follow-up of patients and for prevalence studies.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis

Related Publications

M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
July 2005, Journal of virological methods,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
January 1995, Journal of gastroenterology and hepatology,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
January 1997, Hepatology (Baltimore, Md.),
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
December 1995, The Journal of general virology,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
September 1992, Lancet (London, England),
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
April 1995, The Journal of infectious diseases,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
December 1998, The Tohoku journal of experimental medicine,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
December 1999, Pediatrics international : official journal of the Japan Pediatric Society,
M Lindh, and Y Furuta, and K K Ljunggren, and G Norkrans, and P Horal
January 1996, Human heredity,
Copied contents to your clipboard!